FDA Inspection 1197049 — Novel Laboratories, Inc. d.b.a Lupin Somerset
The FDA completed an inspection of Novel Laboratories, Inc. d.b.a Lupin Somerset on January 13, 2023 in Somerset, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- January 13, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Somerset, NJ (United States)